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PATENT CITATION ANALYSIS AND
PATENT DAMAGES
DR. PETER A. MALASPINA*
INTRODUCTION
In recent years, parties have sought to establish new methods for
estimating patent damages awards that are firmly grounded in economic
principles.1 To this end, some experts have turned to using quantifiable
patent characteristics to ascertain insight into patent values. One such
quantifiable characteristic is the total number of times a given patent has
been cited by subsequently issuing patents (forward citation counts). This
paper provides a discussion of the intuition and existing methods for
analyzing forward citation counts to estimate patent damages awards
(referred to herein as “Patent Citation Analysis.”)2
The use of Patent Citation Analysis is not without its controversies, as
several experts’ Patent Citation Analyses have been excluded by the courts
over concerns about reliability. To address these issues of reliability, this
paper provides a review and discussion of the courts’ orders on the
admissibility of Patent Citation Analysis under the Daubert standard.3 I find
* Chief Economist at the New York State Office of the Attorney General (The views expressed here are
those of the author and do not reflect the views of the New York State Attorney General or the Office’s
Division of Economic Justice). I am grateful to David Churella and Craig Slater for their research
assistance. I am also grateful to Jeremy Petranka, Chris Vellturo, Paul Malherbe, Jeff Boaz, and David
Molin, for their many useful suggestions.
1. Zelin Yang, Damaging Royalties: An Overview of Reasonable Royalty Damages, 29 BERKELEY
TECH. REV. 647, 648 (2014).
2. Patent damages can take the form of lost profits or a reasonable royalty. In order to receive
damages in the form of lost profits, the patent holders must show that, but for the infringement, it would
have made a subset of the infringer’s sales. In the case where the patent holder does not claim (or cannot
demonstrate) lost profits, the patent holder is entitled to damages in the form of a reasonable royalty based
on what the patentee would have received from an arms-length negotiation with the infringer, with both
parties assuming the patent(s) at issue is valid and infringed. (See Mark A. Lemley, Distinguishing Lost
Profits From Reasonable Royalties, 51 WM. & MARY L. REV. 655, 655–56 (2009)).
3. The standard comes from the Supreme Court case Daubert v. Merrell Dow Pharms., Inc., 509
U.S. 579, 598 (1993); The Daubert standard is “used by a trial judge to make a preliminary assessment
of whether an expert’s scientific testimony is based on reasoning or methodology that is scientifically
valid and can properly be applied to the facts at issue.” (See Daubert Standard, LEGAL INFORMATION
INSTITUTE, https://www.law.cornell.edu/wex/daubert_standard (last visited Feb. 28, 2017, 3:56pm)).
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that the courts’ reasons for excluding certain instances of Patent Citation
Analysis stem from findings of fault in each excluded expert’s particular
execution of Patent Citation Analysis. Therefore these exclusions are not
indicative of any inherent unreliability in the analysis generally.
Furthermore, to supplement this discussion on reliability, I present Patent
Citation Analysis methods that may be employed to address the courts’
concerns.
Patent Citation Analysis is an important tool for estimating patent
damages awards. Patent Citation Analysis is particularly valuable in a world
where the products covered by patents are increasingly complex because of
the analysis’s ability to apportion value among multiple patented
technologies that may coexist within a commercial embodiment (i.e., within
a covered product(s)). This paper seeks to facilitate Patent Citation
Analysis’s use as a tool (under the proper circumstances), by providing
clarity on the intuition and methods and discussing the issues of reliability
raised by the courts.
The remainder of this paper is organized as follows: Section II provides
a brief overview of the intuition behind Patent Citation Analysis and the
relevant academic literature; Section III provides an overview of the relevant
case law; Section IV discusses the relevant issues from the case law, and
demonstrates methods of Patent Citation Analysis that address the issues
raised by the courts. Section V offers concluding remarks.
I.

PATENT CITATION ANALYSIS OVERVIEW

In this section, I provide a basic overview of the intuition behind using
patent citation counts to infer an economic value. I also provide a brief
description of the relevant academic literature on the methods used in Patent
Citation Analysis.
A. The Intuition of Patent Citation Analysis
Each U.S. patent contains references to previously issued patents under
the patent’s “References Cited” as a way to identify the relevant patented
inventions in the prior art.4 The empirical foundation of Patent Citation
Analysis exists in the observed counts of forward patent citations—the
number of times a patent has been referenced by subsequently issued patents.
The compilations of these “backward citations” (for each patent) are a
collaborative effort made by the patent applicant, counsel for the applicant,
4. Manuel Trajtenberg, A Penny for Your Quotes: Patent Citations and the Value of Innovations,
21 RAND J. OF ECON. 172, 173 (1990).

234

CHICAGO-KENT JOURNAL OF INTELLECTUAL PROPERTY

Vol 18:1

and the patent examiner.5 Each one of these backwards citations engenders
a forward citation for the referenced patent (i.e., a backwards citation from a
newer patent to an older patent counts as a forward citation for the older
patent received from the newer patent). In Patent Citation Analysis, the total
counts of forward citations (“citation counts”) are used to estimate a patent’s
economic value by comparing citation counts across samples of patents.
The basic intuition for using citation counts as a proxy for economic
value is that patents with relatively high values tend to receive more forward
citations than relatively less valuable patents, all else being equal.6 The logic
behind this intuition is that valuable patented technology will encourage new
yet related innovations, which will increase the number of citations back to
the prior patented technology thereby increasing the citation counts of the
prior patented technology. Using this basic economic framework, one can
estimate the relative economic value of patents. This estimate can be
achieved by comparing citation counts across a sample of comparable
patents, so long as suitable controls are put in place.
B. Literature Review
The evidence that citation counts correlate with patent values is well
documented in the existing economic literature.7 In a 1990 article, Manuel
Trajtenberg found that citation-weighted patent counts are indicative of the
value of innovations using a sample of CT Scanner patents.8 Harhoff et al.
(1997) employs a wider sample of U.S. and German patents that support
“Trajtenberg’s conclusions that patents with greater economic value are

5. Id. at 174.
6. Dietmar Harhoff, et. al, Citations, Family Size, Opposition and the Value of Patent Rights, 32
RES. POL’Y. 1343, 1343–44 (2003); Bronwyn H. Hall et. al, Market Value and Patent Citations, 36 RAND
J. OF ECON. 16, 16–17 (2005); Manuel Trajtenberg, A Penny for Your Quotes: Patent Citations and the
Value of Innovations, 21 RAND J. OF ECON. 172, 172–75 (1990); Adam B. Jaffe & Gaétan de Rassenfosse,
Patent Citation Data in Social Science Research: Overview and Best Practices, 68 J. ASS’N. FOR INFO.
SCI. & TECH. no. 6, 1360, 1364 (2017); Bronwyn H. Hall et. al, The NBER Patent Citations Data File:
Lessons, Insights and Methodological Tools (Nat’l Bureau of Econ. Research, Working Paper No. 8498,
2001).
7. Dietmar Harhoff, et. al, Citations, Family Size, Opposition and the Value of Patent Rights, 32
RES. POL’Y. 1343, 1343–44 (2003); Bronwyn H. Hall et. al, Market Value and Patent Citations, 36 RAND
J. OF ECON. 16, 16–17 (2005); Manuel Trajtenberg, A Penny for Your Quotes: Patent Citations and the
Value of Innovations, 21 RAND J. OF ECON. 172, 172–75 (1990); Adam B. Jaffe & Gaétan de Rassenfosse,
Patent Citation Data in Social Science Research: Overview and Best Practices, 68 J. ASS’N. FOR INFO.
SCI. & TECH. no. 6, 1360, 1364 (2017); Bronwyn H. Hall et. al, The NBER Patent Citations Data File:
Lessons, Insights and Methodological Tools (Nat’l Bureau of Econ. Research, Working Paper No. 8498,
2001).
8. Manuel Trajtenberg, A Penny for Your Quotes: Patent Citations and the Value of Innovations,
21 RAND J. OF ECON. 172, 172–75 & 184–85 (1990).
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more heavily cited in subsequent patents.”9 Gaffe and de Rassenfosse (2016)
provide a meta-analysis of published research on Patent Citation Analysis
and found that “forward citation intensity is, in fact, correlated with
economic value.”10
The literature also contains insight into the common methods for
dealing with patent citation data. For example, Hall et. al. (2001) provides a
discussion of patent data sources and proposes adjustment methods to be
used when analyzing patent citation counts.11 A general resource on the use
of patent citation data exists in the compilation of research papers found in
“Patents, Citations, and Innovations,” by Jaffe and Trajtenberg.12
Also relevant to Patent Citation Analysis are the published estimates of
the distributions of patent values. For example, research by Schankerman
(1998) reports estimates of the distribution of patent values by percentiles
for four industries: pharmaceuticals, chemicals, mechanical, and
electronics.13 Similarly, Harhoff et. al. (1997) estimates the value of patented
inventions using samples of German and U.S. patents.14 The findings from
this research can be utilized within Patent Citation Analysis to calibrate the
imputed values from citation counts (as described in Section IV.C below).
II.

OVERVIEW OF RELEVANT COURT ORDERS

This section provides an account of the recent, publicly available court
orders on the admissibility of Patent Citation Analysis under the Daubert
standard. This account is intended to provide context for the discussion that
follows wherein I address the issues raised by the courts

9. DIETMAR HARHOFF ET AL., CITATION FREQUENCY AND THE VALUE OF PATENTED INNOVATION
1-11 (Centre for Eur. Econ. Res. (ZEW), Discussion Paper No. 97-27, 1997).
10. Adam B. Jaffe & Gaétan de Rassenfosse, Patent Citation Data in Social Science Research:
Overview and Best Practices, 68 J. ASS’N. FOR INFO. SCI. & TECH. no. 6, 1360, 1364 (2017).
11. BRONWYN H. HALL ET. AL, THE NBER PATENT CITATIONS DATA FILE: LESSONS, INSIGHTS
AND METHODOLOGICAL TOOLS (Discussion paper No. 3094, 2001).
12. ADAM B. JAFFE & MANUEL TRAJTENBERG, PATENTS, CITATIONS, AND INNOVATIONS (The
MIT Press 2005).
13. Mark Schankerman, How Valuable is Patent Protection? Estimates by Technology Field, 29
RAND J. OF ECON. 77, 80 (1998).
14. DIETMAR HARHOFF ET. AL., EXPLORING THE TAIL OF PATENTED INVENTION VALUE
DISTRIBUTIONS 279–309 (Econ., Law and Intellectual Prop., Springer US, Discussion Paper No. 97–30,
2003).
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A. Oracle America, Inc. v. Google, Inc.
In 2010, Oracle sued Google, alleging infringement of several of its
patents and copyrights relating to application programming interfaces.15 The
defendant’s damages expert used a Patent Citation Analysis to rank the value
of three of the patents-in-suit relative to a set of 22 other patents.16 The
plaintiff filed a motion to exclude portions of the expert’s damages report. In
an order, the court decided to strike the ranking of one patent (“the ‘104
Patent”), while declining to exclude the rankings of the other two.17
In its order, the court found the expert’s implementation of Patent
Citation Analysis for the ‘104 Patent to be “fatally flawed” because the
expert failed to account for the fact that the ‘104 Patent was re-issued twice
and therefore failed to include citation counts to its predecessor patents.18
The defendants responded to this criticism by arguing that because the ‘104
Patent had been reissued with different claims, “counting citations to
predecessor patents would have been inappropriate.”19
The court was not persuaded by the defendant’s argument, stating:
Patents are not cited for their claim language; instead, patents are
cited if they disclose important ideas material to a later application’s
patentability. That is why the citations are to the entire patent, which
is largely composed of specifications and drawings, not claims. The
predecessor patents to the ‘104 patent had the same specifications and
drawings. Not counting citations to these predecessor patents is
error.20

Therefore, the court excluded the expert’s Patent Citation Analysis with
respect to the ‘104 Patent but did not exclude the Patent Citation Analysis
with respect to the other two patent(s)-in-suit.21

15. Oracle Am., Inc. v. Google Inc, No. C 10-03561 WHA, 2012 WL 877125, at *1 (N.D. Cal. Mar.
15, 2012).
16. Id. at *6.
17. Id. at *5.
18. Id. at *2.
19. Id.
20. Id.
21. Id. at *5.
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B. Realtek Semiconductor Corp. v. LSI Corp.
In 2012, Realtek Semiconductor Corp. sued LSI Corp. for infringement
of two patents relating to Wi-Fi standards.22 The plaintiff’s expert utilized
Patent Citation Analysis to determine the value of two patent portfolios, one
of which contained the patents-in-suit, which the court excluded. 23
The plaintiff’s expert used Patent Citation Analysis to value one patent
portfolio that included the patents-in-suit to another allegedly comparable
patent portfolio by aggregating patent citation counts across each portfolio
of patents. However, the expert did not use Patent Citation Analysis to
apportion value to the patents within the patent portfolio which included the
patents-in-suit (the “802.11 SEP portfolio”). Instead, the plaintiff’s expert
decided to apportion (1/N) value to each patent within the portfolio.24
While not addressing the reliability of Patent Citation Analysis
generally, the court took exception with the expert’s 1/N apportionment of
the entire 802.11 SEP portfolio to each of the patents-in-suit. To this end, the
court noted that the plaintiff’s expert report “indicates that a vast majority
(93 percent) of the citations attributed to LSI’s 802.11 SEP portfolio come
from another patent, which is not one of the patents-in-suit.” 25 Furthermore,
the court noted, that had the plaintiff’s expert “calculated the value of only
the patents-in-suit based on the patent citation analysis, the value revealed
for those two patents would represent only 0.1% of the value of the LSI’s
entire portfolio.”26
C. Finjan Inc. v. Blue Coat Systems Inc.
In 2013, Finjan sued Blue Coat Systems for the infringement of six
patents relating to web security.27 The plaintiff’s expert conducted a patent
citation analysis to value the patents-in-suit, which the court rejected for a
“failure to specifically tie the methodology to the facts of this case.” 28
In its order, the court noted that “[a]lthough a qualitative analysis of
asserted patents based upon forward citations may be probative of a
reasonable royalty in some instances,” the damages expert’s application of
22. Realtek Semiconductor Corp. v. LSI Corp., No. C-12-03451 RMW, 2012 WL 4845628, at *1
(N.D. Cal. Oct. 10, 2012).
23. Realtek Semiconductor Corp. v. LSI Corp., No. C-12-03451-RMW, 2014 WL 46997, at *2
(N.D. Cal. Jan. 6, 2014).
24. Id. at *12–16.
25. Id. at *16.
26. Id. at *3.
27. Finjan, Inc. v. Blue Coat Sys., Inc., No. 13-CV-03999-BLF, 2015 WL 4272870, at *1 (N.D.
Cal. July 14, 2015).
28. Id. at *25.

238

CHICAGO-KENT JOURNAL OF INTELLECTUAL PROPERTY

Vol 18:1

the analysis must be rejected.29 In reaching this conclusion, the court opined
on several areas where the damages expert’s specific execution of the Patent
Citation Analysis failed to align with the “facts of the case,” including:
• Failure to account for the value of the accused features as a
portion of the accused products;
• Failure to account for patent age in the citation analysis; and
• Failure to account for self-citations.30
The court found that the damages expert’s Patent Citation Analysis
“does not account for the value of the accused features as a portion of the
accused products.”31 Finding further that,
use of the forward citation analysis . . . does not demonstrate the value
of the asserted patents in the marketplace in relation to other patents
that cover or potentially cover the infringing and non-infringing
features of the accused products. The resulting apportionment
demonstrates, at most, the asserted patents’ relative value in the
abstract, untethered to any of the facts in this case” and thus failed to
“carefully tie proof of damages to the claimed invention’s footprint
in the market place.32

The court also found that the damages expert’s Patent Citation Analysis
failed to properly account for self-citations and patent age, stating that “two
of the patents-in-suit are related and many of [p]laintiff’s patents reference
one another. Surely a patent’s objective quality cannot be based on the
number of times an inventor cites himself in prosecuting related patents,”
and also noting that “the patent with the highest number of forward citations
is (unsurprisingly) the oldest patent in this suit.”33 The court ultimately found
that the expert’s “straightforward application of a forward citation analysis
without taking into consideration these potential problems renders the
method unreliable.”34

29. Id. at *24.
30. Id. at *24–26; Note, self-citations are forward citations received from a patent owned by the
same entity that controls the patent receiving the forward citation.
31. Id. at *24–25.
32. Id. at *26–27.
33. Id. at *25.
34. Id.

2019

PATENT CITATION ANALYSIS AND PATENT DAMAGES

239

D. Better Mouse Co., LLC v. Steelseries ApS, et al.
In 2014, Better Mouse Co. sued Steelseries for allegedly infringing one
of its patents related to computer controller mouse technology. 35 The
defendant’s damages expert conducted a Patent Citation Analysis for the
patent-in-suit which the court declined to reject under the Daubert
standard.36
With respect to the overall reliability for Patent Citation Analysis as
used in patent damages, the court opined that,
[t]o the extent Plaintiff claims that forward citation analysis is never
relevant for patent valuation, the Court rejects that claim. No binding
authority states that forward citation analysis is per se not relevant to
the facts of any case. Instead, the Federal Circuit has said that
‘damages models are fact-dependent,’ Commonwealth Sci. & Indus.
Research Org. v. Cisco Sys., Inc., 2015-1066, 2015 WL 7783669,
slip. op., at 11 (Fed. Cir. Dec. 3, 2015), and that it is the duty of the
party offering a model to sufficiently tie the model to the facts of the
case in which the model is being applied, Summit 6, 802 F.3d at 1296.
Here, SteelSeries has submitted publications which show that citation
numbers correlate with patent value in several fields. That at least
provides some indication that the basic premises necessary for a
forward citation analysis to apply are present in this case. 37

The Court also found that the expert described his analysis and that the
analysis adjusted for the age and technology of the patents included in the
analysis.38
E. Comcast Cable Commc’ns LLC v. Sprint Commc’ns Co. L.P.
In 2012, Comcast sued Sprint alleging patent infringement.39 The
defendant’s expert used a Patent Citation Analysis which the court declined
to reject under the Daubert standard.40

35. Better Mouse Co., LLC v. Steelseries ApS, et al., No. 2:14-CV-198-RSP, 2016 WL 115686, at
*1 (E.D. Tex. Jan. 9, 2016).
36. Id.
37. Better Mouse Co., LLC v. Steelseries ApS, et al., No. 2:14-CV-198-RSP, 2016 WL 3611528,
at *2 (E.D. Tex. Jan. 5, 2016).
38. Id. at *3.
39. Comcast Cable Commc’ns LLC v. Sprint Commc’ns Co. L.P., 218 F. Supp. 3d 375, 379 (E.D.
Pa. 2016).
40. Id. at 381.
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When considering the plaintiff’s objections to the defendant’s expert’s
use of Patent Citation Analysis, the Court addressed several issues,
including:
• Evidence for patent citations as an indicator of patent value in
the academic literature,
• The reliability of Patent Citation Analysis for patent damages
analysis, and
• Potential adjustments that can be made to the citation
analysis.41
With respect to the academic literature on Patent Citation Analysis and
its admissibility under the Daubert standard, the court noted that
the forward citation method of analysis has been recognized in the
academic literature as reliable since the 1990s. Indeed, one metaanalysis of published research on forward citation analysis . . . found
‘forward citation intensity is, in fact, correlated with economic
value.’ In short, courts have not rejected forward citation analysis
outright.42

With respect to the reliability of Patent Citation Analysis for patent
damages, the Court addressed the plaintiff’s reference to Finjan (described
above)—where an expert’s Patent Citation Analysis was excluded—noting
that Finjan does not reject forward citation analysis outright—rather, that
case recognizes that “a qualitative analysis of asserted patents based upon
forward citations may be probative of a reasonable royalty in some
instances.” 43
The Court also found that the defendant’s expert’s Patent Citation
Analysis sufficiently took into consideration the “facts of the case” by
adjusting for patent age and technology.44 To support this conclusion, the
Court contrasted the defendant’s expert’s Patent Citation Analysis with the
Patent Citation Analysis that was excluded in Finjan, noting that in Finjan,
the expert was excluded because he failed to ‘tie the methodology to
the facts of the case’ and failed to consider ‘potential problems’ with
his method of forward-citation analysis. For example, “many of the
[p]laintiff’s patents reference one another,” and the court observed
that patent value should not be based on ‘the number of times an

41.
42.
43.
44.

Id. at 382–84.
Id. at 383.
Id.
Id. at 384.
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inventor cites himself in prosecuting related patents.’ In contrast, [the
defendant’s expert] tied his analysis to the facts in this case by
adjusting the forward citation method to account for the age and
category of the ‘870 patent and the other patents covered by the
Nokia-Comcast Agreement.45

Therefore, the Court found that defendant’s expert made the necessary
adjustments for age and technology to sufficiently tie the Patent Citation
Analysis to the “facts of the case,” concluding that there was no justification
for rejecting the defendant’s expert’s Patent Citation Analysis under the
Daubert standard.46
III.

ADDRESSING THE ISSUES RAISED BY THE COURT: TYING THE
PATENT CITATION ANALYSIS TO THE FACTS OF THE CASE

The court orders provided above contain both affirmations and
condemnations of Patent Citation Analysis, and have, on occasion, resulted
in the exclusion of expert opinions on Patent Citation Analysis under the
Daubert standard. In my opinion, the reasons offered by the court for these
exclusions are to be interpreted generally as finding fault in each excluded
expert’s specific execution of Patent Citation Analysis and not indicative of
any inherent unreliability in the generalized analysis itself. From this
perspective, the totality of the courts’ findings indicates that the connection
between patent citation counts and patent value is well-established in the
academic literature, and that Patent Citation Analysis is a reliable method to
estimate patent damages under certain conditions when adequate controls are
put in place by tying the analysis to the “facts of the case.”47
The remainder of this Section discusses these issues in the context of
the relevant court orders where the reliability of Patent Citation Analysis was
challenged under the Daubert standard. Therein, I address several of the
issues raised by the courts, including:
• Accounting for the value of the patent(s)-in-suit in the
marketplace for the accused products as distinct from the value
of the patent;
• Controlling for other observable characteristics of each patent
including:
• Patent age,
45. Id. (quoting Finjan, Inc. v. Blue Coat Sys., Inc., No. 13-CV-03999-BLF, 2015 WL 4272870, at
*8 (N.D. Cal. July 14, 2015).
46. Id.
47. See supra Section III.E, where the court found that evidence of a correlation between patent
citation counts and value has been recognized in the academic literature since the 1990s.
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• Field of patent technology,
• Self-citations; and
• How to treat citation counts for re-issued patents.
The discussion of these issues demonstrates existing methods of Patent
Citation Analysis that address the courts’ concerns under certain conditions.
A. Value of the Patent(s)-in-Suit in the Marketplace for the Accused
Products
In Finjan, the court opined that the damages expert for the plaintiff
failed to connect her Patent Citation Analysis to the value of the asserted
patents in the marketplace for the accused products, noting that:
use of the forward citation analysis . . . does not demonstrate the value
of the asserted patents in the marketplace in relation to other patents
that cover or potentially cover the infringing and non-infringing
features of the accused products. The resulting apportionment
demonstrates, at most, the asserted patents’ relative value in the
abstract, untethered to any of the facts in this case. 48

Therefore, the court found that the expert’s Patent Citation Analysis did
not capture the value of the asserted patents in the marketplace because the
analysis was not linked in any way to values of inventions as they exist in
the accused products or other comparable products that practice the patents.49
I share the court’s ’concerns on this issue. In the remainder of this section, I
discuss how these concerns may be addressed within Patent Citation
Analysis though extant licenses to the patent(s)-in-suit—licenses that would
typically be considered under Georgia-Pacific Factor 1. 50
A previous license that specifies a royalty for use of the patent(s)-insuit, that covers products that are comparable to the defendant’s accused
products, is often the best starting point for a reasonable royalty analysis.5152
However, in some cases, the patent(s)-in-suit are not licensed in absolute
isolation within previous licenses, but instead bundled together with rights
48. Finjan, Inc. v. Blue Coat Sys., Inc., No. 13-CV-03999-BLF, 2015 WL 4272870, at *8 (N.D.
Cal. July 14, 2015).
49. Id.
50. The fifteen Georgia-Pacific factors are the most common framework for determining reasonable
royalties. The first factor is the royalties the patentee receives for licensing the patent in suit. See Zelin
Yang, Damaging Royalties: An Overview of Reasonable Royalty Damages, 29 BERKELEY TECH. REV.
647, 651 (2014).
51. Id. at 669.
52. The circumstances of a potentially comparable license and the claimed technology must be
scrutinized to ensure that the licenses are actually sufficiently comparable (See id. at 669).
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to other patents in a portfolio of patents (a “Patent Portfolio”), which is
licensed at a clearly defined royalty (the “Patent Portfolio Royalty”)53 that
covers products that are comparable to the accused products.54 In these
circumstances, the Patent Portfolio Royalty becomes the link between the
Patent Citation Analysis and the “facts of the case” with respect to the value
of asserted patents in the marketplace for the accused products.55
The Patent Portfolio Royalty gives the expert important information
about the value of the patent(s)-in-suit as embodied in the accused products.
Without this information, even if an expert estimates the absolute value of
the patent(s)-in-suit using Patent Citation Analysis alone, the expert would
still need to apportion the value of the patent in the abstract to the value of
the patent as embodied within the accused products without any straightforward method to conduct this apportionment.
Furthermore, calculating the absolute value of the patent in the abstract
places a much stronger burden on the precision of the calibration of known
distributions of patent values to address the particular patent(s)-in-suit.56
Finding a published, comparable estimate of the distributions of value for
patents relating to a particular technology at a particular point in time may
prove difficult.
Alternatively, with the Patent Portfolio Royalty in hand, estimating the
value of the patent(s)-in-suit simplifies to an apportionment of the known
value of the entire Patent Portfolio to the individual member patents.57 This
basic apportionment methodology using Patent Citation Analysis was
employed by the defendant’s expert in Comcast Cable Commc’ns, which the
court allowed under the Daubert standard.5859
53. The Patent Portfolio Royalty can be defined as a lump-sum, percentage of sales, or per-unit
amount.
54. Patent Citation Analysis is limited in that it can only establish the value of patents, so in order
for a Patent Portfolio to be useful for Patent Citation Analysis, the Patent Portfolio Royalty must apply
only for the use of licensed patents (unless there exists a reliable method to apportion the Patent Portfolio
Royalty to the amount that covers the licensed patents as distinct from other elements covered by the
license).
55. In some cases, licenses to the patent(s)-in-suit, even though portfolio licenses, may not exist. In
these cases, experts may attempt to use a comparable license to a comparable patent(s). Once
comparability has been established, if the comparable patent(s) exists within a portfolio, then the methods
for valuing the comparable patent(s) within a portfolio are essentially the same as the methods described
below for valuing the patent(s)-in-suit within a portfolio.
56. For example, by estimating the value of patent(s)-in-suit by taking the percentile rank of citation
counts and linking them to the percentiles of patent values available in the economic literature, without
using any additional information about the value of patent(s)-in-suit.
57. The methods for calculating this apportionment are described below (See infra Section IV.C).
58. Comcast Cable Commc’ns LLC. v. Sprint Commc’ns Co. L.P., 218 F. Supp. 3d 375, 381 (E.D.
Pa. 2016).
59. An analogous apportionment method was employed by the defendant’s expert in Better Mouse
Co., LLC to value patents in an existing portfolio license that were comparable to the patent-in-suit, which
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The Patent Citation Analysis apportionment exercise described above
requires that the expert determine the ranking (in terms of citation counts) of
the patents in the Patent Portfolio relative to other similar patents.60 This
ranking provides a means to assess the relative value of the patents in the
Patent Portfolio. However, before citation counts can be compared across a
sample of patents, the expert must account for factors that may impact the
number of citations a patent receives.
B. Adjustments for Patent Technology and Age
Several of the court rulings discussed above refer to the adjustments
that can be made to improve comparisons of forward citation counts across
patents.61 In particular, the courts have noted experts’ methods (or lack
thereof) for accounting for technology and age.62
Left unaccounted for, a patent’s age (time elapsed since issuance) may
bias its forward citation count because, as the time since issuance increases,
there are more opportunities for the patent to accumulate forward citations
from subsequently issuing patents. Similarly, a patent’s field of technology
may affect the estimated relationship between a patent’s age (time since
issuance) and the patent’s forward citation frequency, as patents from
different fields of technology may accumulate citations at fundamentally
different rates. Therefore, when choosing a sample of patents (a “Patent
Sample”) with which to conduct a Patent Citation Analysis, an expert should
include patents of comparable age and from similar or related fields to the
patents in the Patent Portfolio.63
For the purposes of assessing the technological comparability of
candidate patents for the Patent Sample, a useful set of benchmarks is
provided by organizational patent classification systems.64 For example, the
U.S. Patent Classification System is a system for organizing all U.S. patent
documents and other technical documents into relatively small collections

the Court declined to reject under the Daubert standard. See Better Mouse Co., LLC v. Steelseries ApS,
et al., No. 2:14-CV-198-RSP, 2016 WL 115686, at *4–5 (E.D. Tex. Jan. 9, 2016).
60. This ranking method is noted in the Court’s ruling in Comcast Cable Commc’ns. See Comcast
Cable Commc’ns LLC., 218 F. Supp. at 382.
61. Oracle Am., Inc. v. Google Inc, No. C 10-03561 WHA, 2012 WL 877125, at *2 (N.D. Cal. Mar.
15, 2012); Better Mouse Co., LLC, 2016 WL 115686, at *3; Finjan, Inc. v. Blue Coat Sys., Inc., 13-CV03999-BLF, 2015 WL 4272870, at *6–8 (N.D. Cal. July 14, 2015).
62. Oracle Am., Inc., 2012 WL 877125, at *2 (N.D. Cal. Mar. 15, 2012); Better Mouse Co., LLC,
2016 WL 115686, at *3; Finjan, Inc., 2015 WL 4272870, at *8.
63. BRONWYN H. HALL ET. AL, THE NBER PATENT CITATIONS DATA FILE: LESSONS, INSIGHTS
AND METHODOLOGICAL TOOLS 29–32 (Discussion paper No. 3094, 2001).
64. Id. at 26.
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based on common subject matter.65 Another classification system, which is
particularly useful for more recent patents, is the Cooperative Patent
Classification (“CPC”). The CPC is an endeavor by the European Patent
Office and the U.S. Patent and Trademark Office to harmonize their
classification systems.66
In the absence of other information, an expert can rely on these
classifications to construct a Patent Sample to include patents in similar or
related fields compared to the patents in the Patent Portfolio.67 A potential
starting point in this endeavor is to determine all of the patent classes
represented in the Patent Portfolio and then include all of the patents in those
classes.
To account for any potential bias in age, the expert should choose a
Patent Sample that is representative of the Patent Portfolio in terms of age of
the member patents (given the constraints on technological comparability
discussed above).68 To account for any remaining age bias within the Patent
Sample, the expert may run a regression69 of citation counts on time elapsed
since issuance, where each patent in the Patent Sample provides a single
observation to fit the regression model.
For example, consider the following regression model:
𝐶𝑖𝑡𝑎𝑡𝑖𝑜𝑛𝑠𝑖 = 𝑓(𝑎𝑔𝑒𝑖 | 𝛽) + 𝜀𝑖

Where 𝑓 is a function capturing the relationship between age and
citations, 𝛽 is the set of parameters to be estimated for 𝑓, and for each patent
𝑖 𝐶𝑖𝑡𝑎𝑡𝑖𝑜𝑛𝑠𝑖 is the unadjusted citation count, 𝑎𝑔𝑒𝑖 is the time elapsed since
issuance, and 𝜀𝑖 is the error term.
Once the model parameters have been estimated (𝛽̂ ), the ith residual
from this regression (𝜀̂𝑖 ) is then the “age-adjusted citation count” for each

65. Overview of the U.S. Patent Classification System (USPC), UNITED STATES PATENT AND
TRADEMARK
OFFICE
(Mar.
1,
2017,
2:22pm),
https://www.uspto.gov/sites/default/files/patents/resources/classification/overview.pdf.
66. Overview of the U.S. Patent Classification System (USPC), UNITED STATES PATENT AND
TRADEMARK OFFICE (Mar. 2, 2017, 2:24pm), https://www.uspto.gov/patents-application-process/patentsearch/classification-standards-and-development.
67. The courts reference experts’ uses of patent classes (See Oracle Am., Inc., 2012 WL 877125, at
*3; see Comcast Cable Commc’ns LLC. v. Sprint Commc’ns Co. L.P., 218 F. Supp. 3d 375, 382 (E.D.
Pa. 2016).
68. In Oracle Am., Inc., the court noted that the expert “considered patents that were issued within
three years before or after the subject patent’s issue date.” Oracle Am., Inc., WHA, 2012 WL 877125, at
*2. Similarly, in Comcast Cable Commc’ns, the court noted that the expert included patents published
“within six months before and after” publication of the patent-in-suit. Comcast Cable Commc’ns LLC.,
218 F. Supp. at 382.
69. Regression analysis is a commonly used statistical tool that estimates the relationship between
observed variables. (See Reference Manual on Scientific Evidence 1, 260–68 (Fed. Judicial Ctr., 3d ed.
2011).
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patent 𝑖. For example, if the model predicts an average patent aged 4 years
at the end of 2012 should have 21 citations, but that patent actually has 25
citations, the adjusted citation count for that patent is 4 (= 25 - 21).
C. Valuing the Patents in the Patent Portfolio using Adjusted
Citation Counts
The age-adjusted forward citation counts provide a means to calculate
a percentile ranking for each patent in the Patent Sample.70 The expert can
then match these rankings to percentile rankings of absolute patent values
derived from observations provided in the literature,71 thus assigning each
patent 𝑖’s adjusted citation count a value θi. The resulting relative value
portion for each patent “j” in the Patent Portfolio is then vj , such that vj = (θj
/ ∑θi )* 𝑉, where ∑θi is the sum total of all value estimates θi over each patent
in the Patent Portfolio, and 𝑉 is the total Patent Portfolio Royalty.72
Therefore, given an estimated value vj for each patent-in-suit j, the
estimated royalty is simply vj when the Patent Portfolio Royalty is a lump
sum. In the case where the Patent Portfolio Royalty is given as a percentage
of sales, the estimated royalty for each patent-in-suit is calculated by
multiplying vj, for each patent-in-suit j, by the appropriate measure of total
sales (“Sales”) of the accused products sold during the damages period such
that the total royalty estimate for each patent-in-suit is equal to (vj x Sales),
or in the case where the Patent Portfolio Royalty is a per-unit amount,
multiplying vj by the number of accused units (“Units”) sold during the
damages period (vj x Units).
D. Accounting for Patent Re-issues
In Oracle America, Inc., the court found the expert’s implementation of
Patent Citation Analysis to be “fatally flawed” because the expert failed to

70. In Comcast Cable Commc’ns LLC., the court noted that the expert percentile ranked each patent
in the Patent Portfolio as the basis for approximating the value of the patents in the Patent Portfolio. (See
Comcast Cable Commc’ns LLC., 218 F. Supp. at 383).
71. For an available distribution of patent values, an expert can turn to estimates of patent values
reported by percentile in Schankerman (1998) (See Mark Schankerman, How Valuable is Patent
Protection? Estimates by Technology Field, 29 RAND J. OF ECON. 77–107 (1998). The patent values by
percentile reported in Schankerman can be used to simulate and percentile rank many observations of
patent values for the matching process.
72. In Comcast Cable Commc’ns LLC., the court noted that the expert estimated the value of the
patent-in-suit as a percentage of the Patent Portfolio Royalty. (See Comcast Cable Commc’ns LLC., 218
F. Supp. at 383).
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account for the fact the patent-in-suit was re-issued twice, and therefore
failed to include citation counts to its predecessor patents.73
In its order, the court found that “Patents are not cited for their claim
language; instead, patents are cited if they disclose important ideas material
to a later application’s patentability. That is why the citations are to the entire
patent, which is largely composed of specifications and drawings, not
claims.”74 The predecessor patents to the ‘104 patent had the same
specifications and drawings. Not counting citations to these predecessor
patents is error.”75 In light the court’s perspective, an expert should include
citation counts from predecessor patents in the total citation counts of each
patent-in-suit and the other patents in the Patent Portfolio (to the extent this
information is readily available).
E. Self-Citations
The court’s order in Finjan raises the issue of potential bias as a result
of counting self-citations—a forward citation received by an older patent
from a newer patent when the same commercial entity controls both
patents—in the same manner as any other citation.76 To this point, the court
stated that “[s]urely a patent’s objective quality cannot be based on the
number of times an inventor cites himself in prosecuting related patents.”77
The court’s order in Finjan does not provide any evidence, empirical or
intuitive, as to why self-citations should cause Patent Citation Analysis to be
significantly biased in any systematic way.78 Indeed, the court’s order
seemed to imply that forward self-citations should be discounted by some
factor (relative to forward non-self-citations or “forward organic citations”)
or run the risk of biasing the results.
At the outset, it is prudent to note that, while there is limited research
on the value of forward organic citations compared to forward self-citations,
some evidence suggests that the impact is relatively modest, and that perhaps
surprisingly, that self-cited forward citations are worth somewhat more than
organic forward citations.79
73. See Oracle Am., Inc. v. Google Inc, No. C 10-03561 WHA, 2012 WL 877125, at *2 (N.D. Cal.
Mar. 15, 2012).
74. Id. at *2.
75. Id. at *2.
76. Finjan, Inc. v. Blue Coat Sys., Inc., No. 13-CV-03999-BLF, 2015 WL 4272870, at *7–8 (N.D.
Cal. July 14, 2015).
77. Id.
78. Id.
79. See Bronwyn H. Hall et. al, Market Value and Patent Citations, 36 RAND J. OF ECON. 28–31
(2005).
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Furthermore, even if an expert were to assume self-citations are a
source of potential bias, an expert may address the issue by analyzing the
Patent Portfolio to see if there is evidence of bias in the number of selfcitations.80 The distinction between self-citations and organic citations
should have a relatively limited impact on the analysis unless there is a large
discrepancy in forward self-citations, measured as a percentage of all
forward citations, for the most frequently cited patents within the Patent
Portfolio.81
Given the available evidence, I believe that the court’s fears about the
impact of self-citations are somewhat overstated generally and nevertheless
potentially addressable with additional analysis. In short, an expert should
remain vigilant for sources of significant bias, but not assume a priori, that
any specter of unexplained variation in the data gives cause to abandon the
analysis.
IV.

CONCLUSIONS

Patent Citation Analysis is an important tool for courts to determine
reasonable royalty awards under certain conditions. The discussion
presented above provides the intuition and methods behind Patent Citation
Analysis. This paper also discusses the issues raised by the courts about
Patent Citation Analysis and the methods used to address them. Hopefully,
these discussions will strengthen courts’ understandings of Patent Citation
Analysis, and aid assessments of the appropriateness of its use in a variety
of circumstances.

80. For example, the expert could remove all self-citations from the counts of forward citations, and
see if this has a significant impact on the results of the analysis.
81. The value of the Patent Portfolio will be weighted toward the most cited patents because of the
lognormal distribution of patent values. For a discussion on the assumption that patent values follow a
lognormal distribution, see Jonathan A. Barney, A Study of Mortality Rates: Using Statistical Survival
Analysis to Rate and Value Patent Assets, 30 AIPLA Q. J., 317, 326–337.

